Sidhpen 40 Injection
Marketer
Siddhichemo Pharmaceuticals
Salt Composition
Pantoprazole (40mg)
Overview Sidhpen 40 Injection
Gastric acid production is diminished by the intravenous administration of Axipen 40 Injection. This medication treats gastrointestinal disorders stemming from excess stomach acid, including acid reflux, peptic ulcers, and Zollinger-Ellison syndrome, alleviating symptoms and facilitating healing. Axipen 40 Injection also prevents stress ulcers in critically ill patients and is used pre-anesthesia to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), it's administered intravenously by a medical professional only when deemed more appropriate than oral medication. Dosage is individualized based on your condition and response, with treatment duration determined by your physician. Consistent use as prescribed is crucial, even with rapid symptom resolution. Lifestyle modifications, such as frequent small meals and avoidance of caffeine, spicy, and fatty foods, enhance treatment efficacy. Common, generally mild, side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, abdominal pain, and thrombophlebitis (vein inflammation). Persistent or bothersome side effects warrant medical attention. Prolonged use, particularly exceeding one year, may increase the risk of bone fractures, especially at higher doses. Discuss bone health preservation strategies, such as calcium and vitamin D supplementation, with your doctor. Axipen 40 Injection is contraindicated for individuals with severe hepatic impairment, those on HIV medications, those with a history of similar medication allergies, or pre-existing osteoporosis. Pregnant or lactating individuals should consult their doctor before use. Alcohol consumption should be avoided due to its acid-stimulating effect. Refrain from operating machinery if dizziness or drowsiness occurs.
Primary Ingredients of Sidhpen 40 Injection
No text provided. Please provide the text you wish to be rephrased.
Uses of Sidhpen 40 Injection
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Sidhpen 40 Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Sidhpen 40 Injection:
- Diarrhea
- Flatulence
- Headache
- Joint pain
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Thrombophlebitis
How to use Sidhpen 40 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Sidhpen 40 Injection works:
Gastric acid secretion is diminished by Sidhpen 40 Injection, a proton pump inhibitor (PPI), thus alleviating heartburn and acid indigestion.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Sidhpen 40 Injection is dangerous.
PregnancyCONSULT YOUR DOCTOR
Administering Sidhpen 40 Injection during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against potential dangers prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Sidhpen 40 Injection safely. Available human data indicates minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Sidhpen 40 Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Sidhpen 40 Injection poses no safety concerns for individuals with renal impairment; no dosage modification is necessary.
LiverCAUTION
For individuals with advanced liver impairment, administering Sidhpen 40 Injection requires careful consideration. The Sidhpen 40 Injection dosage might necessitate modification. A physician's consultation is recommended.
What if you forget to take Sidhpen 40 Injection :
Omit a Sidhpen 40 Injection dose? Seek medical advice immediately.
Facts to Know About Sidhpen 40 Injection
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Action Class | Gastric acid suppressants |



